Related Experiment Videos
Enterohepatic circulation model for population pharmacokinetic analysis
1Clinical Pharmacology Group, Nippon Roche K. K., Tokyo, Japan.
The Journal of Pharmacy and Pharmacology
|December 1, 1999
Summary
A new physiological model accurately describes enterohepatic circulation for drugs like mycophenolate mofetil. This pharmacokinetic model aids in understanding drug behavior and evaluating racial differences.
Area of Science:
- Pharmacokinetics
- Drug Metabolism and Transport
- Physiological Modeling
Background:
- Enterohepatic circulation significantly impacts drug pharmacokinetics.
- Accurate modeling is crucial for understanding drug disposition and variability.
- Mycophenolate mofetil exhibits enterohepatic recirculation.
Purpose of the Study:
- To develop a physiologically based enterohepatic circulation model for population pharmacokinetic analysis.
- To validate the model using mycophenolate mofetil.
- To compare pharmacokinetics across different races using the developed model.
Main Methods:
- Development of a novel enterohepatic circulation model incorporating biliary excretion.
- Population pharmacokinetic analysis of mycophenolate mofetil.
- Model validation and covariate analysis.
Main Results:
- The developed enterohepatic model accurately described the plasma concentration-time profile of mycophenolate mofetil.
- A distinct secondary peak indicating enterohepatic circulation was well-defined.
- Model-predicted covariates aligned with existing literature findings.
Conclusions:
- The new physiological model effectively captures enterohepatic circulation for drugs.
- This model is valuable for evaluating drug covariates and understanding inter-individual variability.
- Population pharmacokinetic analysis using this model can assess racial differences in drug disposition.